Evidence map›Paper›PMID 32220293›Full record

ArticleAmerican journal of human genetics2020

Incidence, Origin, and Predictive Model for the Detection and Clinical Management of Segmental Aneuploidies in Human Embryos.

Laura Girardi, Munevver Serdarogullari, Cristina Patassini, Maurizio Poli, Marco Fabiani, Silvia Caroselli, Onder Coban, Necati Findikli, Fazilet Kubra Boynukalin, Mustafa Bahceci and 9 more

Open access · bronzeAbstract read
In one paragraph

Article in American journal of human genetics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed, 4 pooled it
20.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 4 syntheses or guidelines pooled it, 105 citations in OpenAlex.

  1. Pooled it
  2. Guideline
  3. Pooled it
  4. Pooled it
  5. Observational
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 9 institutions in 7 countries.

Laura GirardiIgenomix Italy, 36063, Marostica, Italy.
Munevver SerdarogullariBritish Cyprus IVF Hospital, 2681, Nicosia, Cyprus.
Cristina PatassiniIgenomix Italy, 36063, Marostica, Italy.
Maurizio PoliIgenomix Italy, 36063, Marostica, Italy.
Marco FabianiIgenomix Italy, 36063, Marostica, Italy.
Silvia CaroselliIgenomix Italy, 36063, Marostica, Italy.
Onder CobanBritish Cyprus IVF Hospital, 2681, Nicosia, Cyprus.
Necati FindikliBahceci Fulya IVF Centre, Embryology Laboratory, 34394, Istanbul, Turkey; Department of Biomedical Engineering, Beykent University, Ayazaga, Hadim Koruyolu Cd. No:19, 34398 Sariyer/İstanbul.
Fazilet Kubra BoynukalinBahceci Fulya IVF Centre, Infertility Clinic, 34394, Istanbul, Turkey.
Mustafa BahceciBahceci Fulya IVF Centre, Infertility Clinic, 34394, Istanbul, Turkey.
Rupali ChopraIgenomix FZ LLC, Unit 501-502, Building 40, Dubai Health Care City, Dubai, UAE, PO Box 66566.
Rita CanipariDAHFMO, Unit of Histology and Medical Embryology, Sapienza, University of Rome, 00161, Roma, Italy.
Danilo CimadomoGenera, Centers for Reproductive Medicine-Clinica Valle Giulia, 00197, Roma, Italy.
Laura RienziGenera, Centers for Reproductive Medicine-Clinica Valle Giulia, 00197, Roma, Italy.
Filippo UbaldiGenera, Centers for Reproductive Medicine-Clinica Valle Giulia, 00197, Roma, Italy.
Eva HoffmannDRNF Center for Chromosome Stability, Department of Cellular and Molecular Medicine, University of Copenhagen, 2200 N, Copenhagen, Denmark.
Carmen RubioIgenomix Foundation, 46980, Valencia, Spain.
Carlos SimonIgenomix Foundation, 46980, Valencia, Spain; Department of Obstetrics and Gynecology, Valencia University, Valencia, 46010, Spain; INCLIVA, Valencia, 46010, Spain; Department of Obstetrics and Gynecology, Harvard School of Medicine, Harvard University, 02115, Boston, MA, USA.
Antonio CapalboIgenomix Italy, 36063, Marostica, Italy; DAHFMO, Unit of Histology and Medical Embryology, Sapienza, University of Rome, 00161, Roma, Italy; Igenomix Foundation, 46980, Valencia, Spain. Electronic address: antonio.capalbo@igenomix.com.
Igenomix · ITClinica Valle Giulia · ITIgenomix · ESNicosia General Hospital · CYBeykent University · TRDubai Health Authority · AEHarvard University · USSapienza University of Rome · ITUniversity of Copenhagen · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite next-generation sequencing, which now allows for the accurate detection of segmental aneuploidies from in vitro fertilization embryo biopsies, the origin and characteristics of these aneuploidies are still relatively unknown. Using a multifocal biopsy approach (four trophectoderms [TEs] and one inner cell mass [ICM] analyzed per blastocyst; n = 390), we determine the origin of the aneuploidy and the diagnostic predictive value of segmental aneuploidy detection in TE biopsies toward the ICM's chromosomal constitution. Contrary to the prevalent meiotic origin of whole-chromosome aneuploidies, we show that sub-chromosomal abnormalities in human blastocysts arise from mitotic errors in around 70% of cases. As a consequence, the positive-predictive value toward ICM configuration was significantly lower for segmental as compared to whole-chromosome aneuploidies (70.8% versus 97.18%, respectively). In order to enhance the clinical utility of reporting segmental findings in clinical TE biopsies, we have developed and clinically verified a risk stratification model based on a second TE biopsy confirmation and segmental length; this model can significantly improve the prediction of aneuploidy risk in the ICM in over 86% of clinical cases enrolled. In conclusion, we provide evidence of the predominant mitotic origin of segmental aneuploidies in preimplantation embryos and develop a risk stratification model that can help post-test genetic counseling and that facilitates the decision-making process on clinical utilization of these embryos.

Indexed as

AneuploidyBlastocystChromosome AberrationsChromosomesComparative Genomic HybridizationEmbryo, MammalianEmbryonic DevelopmentFemaleFertilization in VitroHumansIncidencePregnancyPreimplantation DiagnosisaneuploidiesIVFmeiosismitotic aneuploidiesmosaicismPGTpreimplantation embryopreimplantation genetic testingpreimplnatation genetic screeningsegmental abnormalities

Identifiers

PMID32220293
PMCPMC7118577
OpenAlexW3013478170

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.